Biochemical firm sees sharp rise in net profit
Hong Kong-listed corn-based biochemical manufacturer Fufeng Group has seen a sharp increase in its interim net profit on the back of a thriving mainland economy.
The mainland-based company says that its net profit attributable to shareholders rose about 30 per cent year-on-year to 460.1 million yuan (HK$525.7 million) for the period ending June 30.
'In the first half of 2010, the MSG [monosodium glutamate] industry thrived thanks to the robust performance of China's economy,' says Li Xuechun, chairman of Fufeng.
Despite intense competition and higher raw material costs, the group leveraged on its leading position in the industry and transferred the rising price of raw materials to clients, maintaining the gross profit margin of its MSG segment at a high level.
With the strong sales performance of MSG products and xanthan gum, and the expansion of production capacity, the group further enlarged its market share.
During the period under review, the group's growth continued and it achieved good sales performance in MSG and xanthan gum segments. Turnover for the period rose 45.4 per cent year-on-year to 2.99 billion yuan.